Literature DB >> 15280615

Intermittent hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency.

Sheffali Gulati1, Shaji Menon, Madhulika Kabra, Veena Kalra.   

Abstract

Ornithine transcarbamylase (OTC) deficiency is an X-linked disorder and the most common inherited cause of hyperammonemia. Clinical manifestations are more severe in hemizygous males who often present in neonatal period. Heterozygous females may be asymptomatic until juvenile or adulthood. Fluctuating concentration of ammonia, glutamine and other excitotoxic amino acids result in a chronic or episodically recurring encephalopathy. The authors report a heterozygous female with OTC deficiency who presented with recurrent encephalopathy.

Entities:  

Mesh:

Year:  2004        PMID: 15280615     DOI: 10.1007/BF02724127

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  6 in total

1.  Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency.

Authors:  M Oechsner; C Steen; H J Stürenburg; A Kohlschütter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

Review 2.  [Enzyme defects of the urea cycle in differential acute encephalopathy diagnosis in adulthood. Diagnosis and current therapy concepts].

Authors:  S Schwarz; S Schwab; G F Hoffmann
Journal:  Nervenarzt       Date:  1999-02       Impact factor: 1.214

3.  Current strategies for the management of neonatal urea cycle disorders.

Authors:  M Summar
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

4.  Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis.

Authors:  N E Maestri; D Clissold; S W Brusilow
Journal:  J Pediatr       Date:  1999-03       Impact factor: 4.406

5.  Natural history of symptomatic partial ornithine transcarbamylase deficiency.

Authors:  P C Rowe; S L Newman; S W Brusilow
Journal:  N Engl J Med       Date:  1986-02-27       Impact factor: 91.245

6.  Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy.

Authors:  C L Pridmore; J T Clarke; S Blaser
Journal:  J Child Neurol       Date:  1995-09       Impact factor: 1.987

  6 in total
  1 in total

Review 1.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.